MedTrace Logo

SAFEty of Two Strategies of ICD Management at Implantation

NCT00661037 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2120

Last updated 2017-07-21

Study results available
· View outcomes & findings →

Summary

The aim of this prospective observational study is to evaluate the safety, over a follow-up of 2 years, of two strategies, consisting in performing or not performing defibrillation testing(DT) during first implant of implantable cardioverter defibrillator

Conditions

Interventions

DEVICE

Implantable defibrillator

Implantable defibrillator to reduce ventricular arrhythmias via shock.

DEVICE

Implantable defibrillator

Implantable defibrillator to reduce ventricular arrhythmias via shock.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Michele Brignole, MD · Ospedali del Tigullio

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-05-31
Completion
2011-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00661037 on ClinicalTrials.gov